首页> 外文期刊>Indian Journal of Experimental Biology >Evaluation of vaccine candidate potential of AaroA, AhtrA and AaroAAhtrA mutants of Salmonella enterica subspecies enterica serovar Abortusequi in guinea pigs
【24h】

Evaluation of vaccine candidate potential of AaroA, AhtrA and AaroAAhtrA mutants of Salmonella enterica subspecies enterica serovar Abortusequi in guinea pigs

机译:豚鼠肠炎沙门氏菌亚种血清型Abortusequi AaroA,AhtrA和AaroAAhtrA突变体的疫苗候选潜力评估

获取原文
获取原文并翻译 | 示例
           

摘要

Salmonella enterica subspecies enterica serovar Abortusequi (S. Abortusequi), a host adapted Salmonella causes abortions, still births and foal mortality in equids. Though known since more than 100 years, it is still a problem in many of the developing countries including India. There is dearth of really good vaccine affording immunity lasting at least for one full gestation. In search of a potential vaccine candidate, three defined deletion mutants (AaroA, AhtrA and AaroAAhtrA) of S. Abortusequi were tested in guinea pig model for attenuation safety, immunogenicity, humoral immune response, protective efficacy and persistence in host. The AhtrA and AaroAAhtrA mutants were found to be safe on oral inoculation in doses as high as 4.2xl0~9 cfu/animal.Also through subcutaneous inoculation AaroAAhtrA mutant did not induce any abortion in pregnant guinea pigs. All the three mutants did not induce ajiy illness or death in 1-2 week-old baby guinea pigs except AhtrA mutant which caused mortality on intraperitoneal inoculation. Inoculation with mutants protected against challenge and increased breeding efficiency of guinea pigs. After >4.5 months of mutant inoculation, guinea pigs were protected against abortifacient dose of wild type S. Abortusequi and mother guinea pigs also conferred resistance to their babies to the similar challenge. Early humoral immune response of S. Abortusequi mutants was characteristic. Faecal excretion of AaroA and htrA mutants was detected up to 45 days of inoculation in guinea pigs while AaroAAhtrA mutant could not be detected after 21 days of inoculation. The results indicated that the double deletion mutant (AaroAAhtrA) was the most effective and safe candidate for vaccination against S. Abortusequi through mucosal routeof inoculation.
机译:肠道沙门氏菌亚种Enterica serovar Abortusequi(S. Abortusequi)是一种适应性沙门氏菌的宿主,可引起流产,死产和马驹死亡。尽管它已经有100多年的历史了,但在包括印度在内的许多发展中国家中仍然是一个问题。缺乏真正能提供至少持续一个完整妊娠的免疫力的良好疫苗。为了寻找潜在的疫苗候选者,在豚鼠模型中测试了S. Abortusequi的三个定义的缺失突变体(AaroA,AhtrA和AaroAAhtrA)的减毒安全性,免疫原性,体液免疫应答,保护功效和对宿主的持久性。已发现AhtrA和AaroAAhtrA突变体对动物的口服接种剂量高达4.2x10〜9 cfu /动物,并且通过皮下接种也不会对怀孕的豚鼠产生任何流产。除AhtrA突变体在腹膜内接种时导致死亡外,所有这三个突变体均未在1-2周龄的豚鼠中诱发恶性疾病或死亡。接种突变体可以防止豚鼠受到攻击并提高繁殖效率。在> 4.5个月的突变疫苗接种后,保护豚鼠免于堕胎剂量的野生型S。Abortusequi和豚鼠母鼠也赋予了其婴儿抵抗类似挑战的能力。 S. Abortusequi突变体的早期体液免疫反应是特征。在豚鼠中接种最多45天后,便检测到AaroA和htrA突变体的粪便排泄,而在接种21天后未检测到AaroAAhtrA突变体。结果表明,双缺失突变体(AaroAAhtrA)是通过粘膜接种途径接种S. Abortusequi的最有效,最安全的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号